High Infiltration of CD68+/CD163- Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma.

Svensson, Maria C; Svensson, Maja; Nodin, Björn; Borg, David; Hedner, Charlotta; Hjalmarsson, Claes; Leandersson, Karin; Jirström, Karin

Svensson, Maria C; Svensson, Maja; Nodin, Björn; Borg, David; Hedner, Charlotta; Hjalmarsson, Claes; Leandersson, Karin; Jirström, Karin.

Afiliação

Svensson MC; Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
Svensson M; Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
Nodin B; Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
Borg D; Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
Hedner C; Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
Hjalmarsson C; Department of Clinical Sciences Lund, Oncology, Lund University, Lund, Sweden.
Leandersson K; Cancer Immunology, Department of Translational Medicine, Lund University, Malmö, Sweden.
Jirström K; Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.

J Innate Immun ; 14(6): 615-628, 2022.

Article em En | MEDLINE | ID: mdl-35504250

Assuntos

Terapia Neoadjuvante; Humanos; Prognóstico

Palavras-chave

Esophageal cancer; Gastric cancer; Neoadjuvant chemotherapy; Tumor-associated macrophages

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google